Education
About Us
Working with TipRanks
Follow Us
Brainsway Ltd (BRSYF)
OTHER OTC:BRSYF
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 13, 2025
|% Change Since: 0.00%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
BrainsWay's earnings call highlighted strong revenue growth and an increase in system shipments, alongside advancements in clinical trials and positive cash flow. However, these positives were countered by increased operating expenses and ongoing monitoring of geopolitical and tariff risks.Company Guidance
During BrainsWay's first quarter 2025 earnings call, significant guidance was provided highlighting the company's robust financial performance and strategic focus. The company reported $11.5 million in revenue, marking a 27% year-over-year increase, and shipped 81 Deep TMS systems, a 42% increase from the previous year. Gross margins remained strong at 75%, and operating income rose to $576,000, with adjusted EBITDA reaching $1.3 million. The company reiterated its full-year 2025 revenue guidance of $49 million to $51 million, representing a 20% to 24% growth over 2024. They anticipate generating an operating income of 3% to 4% and adjusted EBITDA margin of 11% to 12% for the year. BrainsWay emphasized its strategic initiatives around market expansion, particularly for its Deep TMS systems in treating OCD and anxious depression, and is advancing clinical trials for new treatment protocols, including an accelerated protocol for major depressive disorder. The company is also exploring opportunities with psychedelic treatments and expects to submit trial data to the FDA by the end of the year. Despite monitoring geopolitical and tariff impacts, BrainsWay does not foresee material adverse effects on its gross margin in the current year.Significant Revenue Growth
BrainsWay reported $11.5 million in revenue for Q1 2025, marking a 27% year-over-year increase.
Increase in Deep TMS System Shipments
The company shipped 81 Deep TMS systems, a 42% increase compared to the first quarter of 2024.
Positive Cash Flow and Strong Gross Margin
The company reported a gross margin of 75% and positive cash flow from operations.
Expansion in OCD Treatment
OCD coils shipped totaled 57, bringing the global installed base to nearly 850.
Advancements in Clinical Trials
The company is advancing U.S. clinical trials for accelerated treatment protocols and working on data for PTSD and adolescent MDD treatments.
BRSYF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BRSYF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2025 | $3.40 | $3.40 | 0.00% |
Mar 11, 2025 | $4.71 | $4.90 | +4.03% |
Nov 12, 2024 | $3.15 | $3.15 | 0.00% |
Aug 06, 2024 | $2.10 | $2.10 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Brainsway Ltd (BRSYF) report earnings?
Brainsway Ltd (BRSYF) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Brainsway Ltd (BRSYF) earnings time?
Brainsway Ltd (BRSYF) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BRSYF EPS forecast?
Currently, no data Available